MiMedx Group, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6024961012
USD
4.41
0.03 (0.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
118.09
113.72
98.61
88.20
92.91
84.06
87.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
118.09
113.72
98.61
88.20
92.91
84.06
87.21
Raw Material Cost
19.18
18.83
18.78
16.66
17.10
15.51
15.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.41
0.42
0.47
0.00
2.53
0.00
0.00
Selling and Distribution Expenses
73.07
69.00
64.15
59.97
61.04
53.52
55.40
Other Expenses
0.44
0.33
0.28
0.33
0.10
0.29
0.30
Total Expenditure (Excl Depreciation)
97.02
91.53
86.23
79.95
81.72
71.95
73.46
Operating Profit (PBDIT) excl Other Income
21.099999999999998
22.200000000000003
12.4
8.299999999999999
11.200000000000001
12.1
13.700000000000001
Other Income
1.12
1.08
1.11
0.36
2.72
0.26
-0.23
Operating Profit (PBDIT)
25.42
28.56
16.65
11.81
14.63
12.49
23.98
Interest
0.41
0.42
0.47
0.00
2.53
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
-0.09
-0.30
0.00
Gross Profit (PBDT)
98.91
94.89
79.82
71.55
75.81
68.54
72.16
Depreciation
3.22
5.29
3.16
3.20
0.76
0.77
0.77
Profit Before Tax
21.80
22.85
13.01
8.61
11.25
11.42
23.22
Tax
6.60
6.10
3.39
1.59
3.81
3.54
5.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
15.19
16.75
9.62
7.02
7.44
7.88
17.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
15.19
16.75
9.62
7.02
7.44
7.88
17.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.19
16.75
9.62
7.02
7.44
7.88
17.62
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
256.55
238.95
216.62
202.78
193.11
181.01
168.04
Earnings per share (EPS)
0.1
0.11
0.06
0.05
0.05
0.05
0.12
Diluted Earnings per share
0.1
0.11
0.06
0.05
0.05
0.05
0.12
Operating Profit Margin (Excl OI)
17.85%
19.51%
12.55%
9.35%
12.0%
13.63%
26.89%
Gross Profit Margin
21.18%
24.74%
16.4%
13.39%
12.92%
14.5%
27.5%
PAT Margin
12.86%
14.73%
9.75%
7.96%
8.01%
9.37%
20.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.87% vs 15.31% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -8.98% vs 73.96% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -11.64% vs 77.42% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -20.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of MiMedx Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
118.09
180.90
-62.81
-34.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
118.09
180.90
-62.81
-34.72%
Raw Material Cost
19.18
94.90
-75.72
-79.79%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.41
1.90
-1.49
-78.42%
Selling and Distribution Expenses
73.07
77.70
-4.63
-5.96%
Other Expenses
0.44
0.42
0.02
4.76%
Total Expenditure (Excl Depreciation)
97.02
178.70
-81.68
-45.71%
Operating Profit (PBDIT) excl Other Income
21.08
2.20
18.88
858.18%
Other Income
1.12
2.00
-0.88
-44.00%
Operating Profit (PBDIT)
25.42
14.10
11.32
80.28%
Interest
0.41
1.90
-1.49
-78.42%
Exceptional Items
0.00
-1.10
1.10
100.00%
Gross Profit (PBDT)
98.91
86.00
12.91
15.01%
Depreciation
3.22
9.90
-6.68
-67.47%
Profit Before Tax
21.80
1.20
20.60
1,716.67%
Tax
6.60
2.50
4.10
164.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
15.19
-1.30
16.49
1,268.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
15.19
-1.30
16.49
1,268.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.19
-1.30
16.49
1,268.46%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
256.55
778.20
-521.65
-67.03%
Earnings per share (EPS)
0.10
-0.03
0.13
433.33%
Diluted Earnings per share
0.10
-0.03
0.13
433.33%
Operating Profit Margin (Excl OI)
17.85%
1.22%
0.00
16.63%
Gross Profit Margin
21.18%
6.14%
0.00
15.04%
PAT Margin
12.86%
-0.72%
0.00
13.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.81 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.87% vs 15.31% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 27.13% vs 7.03% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.52 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -8.98% vs 73.96% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 105.41% vs -85.58% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -11.64% vs 77.42% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 104.20% vs -26.99% in Dec 2024

Quarterly - Interest
Interest 0.04 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -20.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -84.00% vs 56.25% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.85%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024